Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients
暂无分享,去创建一个
V. Álvarez | E. Coto | P. Avanzas | María Martín | C. Morís | B. Díaz-Molina | J. Reguero | R. Lorca | S. Tranche | B. Alonso | S. Iglesias | Juan Gómez
[1] X. Puente,et al. Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C , 2016, European Journal of Human Genetics.
[2] V. Álvarez,et al. KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort , 2016, Molecular and Cellular Endocrinology.
[3] L. Monserrat,et al. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. , 2016, The Journal of Heart and Lung Transplantation.
[4] J. Schwartzentruber,et al. Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human mutation.
[5] M. Ackerman,et al. Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue. , 2015, Heart rhythm.
[6] J. Southern,et al. BAG3 myofibrillar myopathy presenting with cardiomyopathy , 2015, Neuromuscular Disorders.
[7] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[8] Y. Pinto,et al. Genetic advances in sarcomeric cardiomyopathies: state of the art , 2015, Cardiovascular research.
[9] Lorenzo L. Pesce,et al. Targeted Analysis of Whole Genome Sequence Data to Diagnose Genetic Cardiomyopathy , 2014, Circulation. Cardiovascular genetics.
[10] V. Álvarez,et al. Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[11] X. Puente,et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.
[12] Giuseppe Limongelli,et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.
[13] E. Coto,et al. Effect of the FTO rs9930506 Polymorphism on the Main Comorbidities of the Cardiorenal Metabolic Syndrome in an Elderly Spanish Cohort , 2014, Cardiorenal Medicine.
[14] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[15] V. Álvarez,et al. Non Optical Semi-Conductor Next Generation Sequencing of the Main Cardiac QT-Interval Duration Genes in Pooled DNA Samples , 2014, Journal of Cardiovascular Translational Research.
[16] J. Kautzner,et al. Isolated X-Linked Hypertrophic Cardiomyopathy Caused by a Novel Mutation of the Four-and-a-Half LIM Domain 1 Gene , 2013, Circulation. Cardiovascular genetics.
[17] V. Álvarez,et al. The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain). , 2013, International journal of cardiology.
[18] G. Bonne,et al. ‘State-of-the-heart’ of cardiac laminopathies , 2013, Current opinion in cardiology.
[19] Katherine H. Schreiber,et al. When Lamins Go Bad: Nuclear Structure and Disease , 2013, Cell.
[20] Claudia Giambartolomei,et al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing , 2013, Journal of Medical Genetics.
[21] J. Svendsen,et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants , 2013, European Journal of Human Genetics.
[22] S. Gabriel,et al. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. , 2012, American journal of human genetics.
[23] Donald Wolfgeher,et al. Population-Based Variation in Cardiomyopathy Genes , 2012, Circulation. Cardiovascular genetics.
[24] Eloisa Arbustini,et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. , 2012, Human molecular genetics.
[25] Robert H. Brown,et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. , 2011, American journal of human genetics.
[26] A. Gonzalez-Perez,et al. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.
[27] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[28] I. Ferrer,et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy , 2009, European Journal of Human Genetics.
[29] C. Heyer,et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. , 2007, Brain : a journal of neurology.
[30] T. Holak,et al. Filamins: promiscuous organizers of the cytoskeleton. , 2006, Trends in biochemical sciences.
[31] H. Wajcman,et al. In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. , 2004, Clinical chemistry.
[32] C. Walsh,et al. The many faces of filamin: A versatile molecular scaffold for cell motility and signalling , 2004, Nature Cell Biology.
[33] F. Mastaglia,et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). , 2004, American journal of human genetics.
[34] E. Coto,et al. The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy. , 2016, Revista espanola de cardiologia.
[35] M. Vorgerd,et al. Filamin C-related myopathies: pathology and mechanisms , 2012, Acta Neuropathologica.
[36] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.